Showing results (51-60 of 133) with videos related to
Sort By:
Pageof 14
Tissue Engineering. Part A|July 3, 2013
Hybrid hydroxyapatite nanoparticle colloidal gels are injectable fillers for bone tissue engineeringQun Wang, Zhen Gu, Syed Jamal, et al.Journal of Pharmaceutical Sciences|May 24, 2012
Development of budesonide nanocluster dry powder aerosols: formulation and stabilityNashwa El-Gendy, Shan Huang, Parthiban Selvam, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2002
Precise control of PLG microsphere size provides enhanced control of drug release rateCory Berkland, Martin King, Amanda Cox, et al.Journal of Pharmaceutical Sciences|January 9, 2009
Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolutionNashwa El-Gendy, Eric M Gorman, Eric J Munson, et al.Langmuir : the ACS Journal of Surfaces and Colloids|October 31, 2008
Pure insulin nanoparticle agglomerates for pulmonary deliveryMark M Bailey, Eric M Gorman, Eric J Munson, et al.Biomaterials|March 23, 2010
Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defectsQun Wang, Jinxi Wang, Qinghua Lu, et al.Langmuir : the ACS Journal of Surfaces and Colloids|March 22, 2013
Hyaluronic acid nanoparticles titrate the viscoelastic properties of viscosupplementsAmir Fakhari, Quang Phan, Santosh V Thakkar, et al.International Journal of Pharmaceutics|December 31, 2013
NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilationWarangkana Pornputtapitak, Nashwa El-Gendy, Joel Mermis, et al.Journal of Pharmaceutical Sciences|October 6, 2010
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1Amir Fakhari, Abdulgader Baoum, Teruna J Siahaan, et al.ACS Nano|March 8, 2011
Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift responseChuda Chittasupho, Laura Shannon, Teruna J Siahaan, et al.Pageof 14